Sanguine Corporation
101 East Green Street, #101
Pasadena, California 91105
November 10, 2000
Westbury Consultancy Services Ltd.
8, Rue des Morillons
75014 Paris, France
Attention: Dr. Louis Leclerc
Re: Letter of Westbury Consultancy Services, Ltd.
("Westbury") dated November 7, 2000, respecting its
agreement to reduce the term of the warrants outlined
in that certain Warrant Agreement between Sanguine
Corporation, a Nevada corporation ("Sanguine"), and
Westbury
Dear Mr. Leclerc:
Today, in reliance on your letter dated November 7, 2000, the
Board of Directors unanimously resolved that in consideration of your
reduction of the warrant term in the Warrant Agreement from its present five
year period to one year from the effective date of Sanguine's Registration
Statement registering the shares underlying the warrants granted pursuant to
the Warrant Agreement, that the exercise price will be reduced from $0.30 to
$0.25 per share.
Please acknowledge your acceptance of this proposal, as an
amendment to the Warrant Agreement.
Thank you very much.
Yours very sincerely,
/s/Anthony G. Hargreaves
Vice President and Secretary
cc. Roger Bendelac
Laidlaw Global Securities, Inc.
Leonard W. Burningham, Esq.
ACCEPTED:
WESTBURY CONSULTANCY SERVICES, LTD.
By/s/Dr. Louis Leclerc
